Brief: Idera Pharmaceuticals Posts Q4 Loss Per Share $2.11

Aceragen

01/03/2021 23:56

March 1 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q4 LOSS PER SHARE $2.11
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.23 -- REFINITIV IBES
DATA
    * IDERA PHARMACEUTICALS - ANTICIPATE THAT CURRENT CASH, CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS, WILL FUND OPERATIONS
THROUGH Q2 2022

Source text for Eikon:  ID:nGNX8MjWfH 
Further company coverage:  IDRA.O 

 ((reuters.briefs@thomsonreuters.com;))